Stomatitis News and Research

RSS
Zipper motif mediates SARS-CoV-2 spike trimerization within host cell membrane

Zipper motif mediates SARS-CoV-2 spike trimerization within host cell membrane

SARS-CoV-2 infection is circadian

SARS-CoV-2 infection is circadian

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Mink-derived SARS-CoV-2 mutations reduce antibody effectiveness

Mink-derived SARS-CoV-2 mutations reduce antibody effectiveness

SARS-CoV-2 escape mutations identified against monoclonal antibodies and polyclonal immune sera

SARS-CoV-2 escape mutations identified against monoclonal antibodies and polyclonal immune sera

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

One dose of VSV-vectored vaccine prevents SARS-CoV-2 replication in hamsters

One dose of VSV-vectored vaccine prevents SARS-CoV-2 replication in hamsters

Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered

Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Spike-based DNA vaccine shows excellent protection against SARS-CoV-2 in a hamster model

Spike-based DNA vaccine shows excellent protection against SARS-CoV-2 in a hamster model

How SARS-CoV-2 blocks immune response

How SARS-CoV-2 blocks immune response

Identifying SARS-CoV-2 spike protein mutations resistant to antibodies

Identifying SARS-CoV-2 spike protein mutations resistant to antibodies

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Study shows SARS-CoV-2 cell receptor is a novel target of the gamma-secretase enzyme complex

Study shows SARS-CoV-2 cell receptor is a novel target of the gamma-secretase enzyme complex

Experimental COVID-19 vaccine prevents severe disease in mice

Experimental COVID-19 vaccine prevents severe disease in mice

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Protein uses two different mechanisms to inhibit viral infections

Protein uses two different mechanisms to inhibit viral infections